ME Financial Overview

Comprehensive financial analysis and stock performance data for ME. This dashboard provides key metrics, financial ratios, and interactive charts to help you make informed investment decisions.

ME

23andMe Holding Co.

Healthcare
CEO: Joseph Selsavage
IPO: 2020-11-23
560 employees
$0.61
0.00 (0.00%)

Market Cap

13.34M

Enterprise Value

608K

Revenue (TTM)

189.9M

Net Income

-280,885,000

P/E Ratio

-70.82x

ROE

-552.02%

Valuation Metrics
Market Cap
13M
Enterprise Value
608K
P/E Ratio
-70.82x
P/S Ratio
0.08x
P/B Ratio
511.15x
EV/Sales
0.00x
EV/FCF
-0.00x
Earnings Yield
-1.41%
FCF Yield
-1206.61%
Price to Operating Cash Flow
-107.30x
Gross Margin
53.33%
Margin Metrics
Operating Margin
-114.00%
Net Margin
-134.54%
Pretax Margin
-112.33%
ROIC
-321.13%
Dividends
Payout Ratio
0.00%
Dividend Yield
0.00%
Dividend per Share
$0.00
Return Metrics
ROE
-552.02%
ROCE
-605.14%
ROA
-163.04%
PEG Ratio
-4.03x
Payout Ratio
0.00%
Financial Health
Debt to Assets
18.78%
Net Debt/EBITDA
0.09x
Growth Metrics
3Y Revenue Growth
-16.10%
5Y Revenue Growth
-13.32%
10Y Revenue Growth
-10.25%
3Y Net Income Growth
-3.16%
5Y Net Income Growth
4.33%
10Y Net Income Growth
-2.26%
3Y OCF Growth
4.48%
5Y OCF Growth
5.08%
10Y OCF Growth
-4.37%

Stock Performance

Interactive stock chart with historical price data and comparison tools. Analyze price movements, volume trends, and compare with other stocks or indices.

ME
AugSepSepOctNovDecDecJanFebMarAprAprJul0.22.24.28.1
ME·Total: -28.61%·CAGR: -28.61%
23andMe Holding Co. | Financial Overview | Monexa